Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Share News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 530.00
Bid: 528.00
Ask: 534.00
Change: -6.00 (-1.12%)
Spread: 6.00 (1.136%)
Open: 540.00
High: 540.00
Low: 526.00
Prev. Close: 536.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury Publishing Increases Pretax Profits, Revenues Boosted By New Book Programme

Thu, 24th Oct 2013 08:23

LONDON (Alliance News) - Bloomsbury Publishing PLC saw increases in revenue and pretax profit in the half-year ended August 31 as it benefited from a new book programme and the sale of a few titles to be produced into films.

The company posted a pretax profit of GBP1.1 million, up 33% from GBP900,000 in the previous year. Revenues were GBP49.2 million, up 13% from GBP43.5 million.

Bloomsbury posted an interim dividend of 0.98 pence per share, up 4% from 0.94 pence in the previous year.

The rights of Samantha Shannon's 'The Bone Season', were acquired by 20th Century Fox and Chernin Entertainment for a new film during the period. This, and sales of Khaled Hosseini's, 'And the Mountains Echoed' helped to drive a 77% increase in the company's Adult division, Bloomsbury said. New acquisitions Fairchild Books and Applied Visual Arts Publishing also contributed to rising revenues.

E-book revenues were up 14% overall to GBP5.1 million, particularly in the UK where e-book sales jumped 58%. In the US, however, e-book sales were down 20%.

The company cautioned that it expected results to be significantly second-half weighted due to peak sales times over Christmas and academic titles selling in Autumn to coincide with the beginning of the academic year.

"The group is well positioned to build on the success of the first-half of the year and continue to progress its strategy of leveraging Bloomsbury's significant intellectual property, its strong brand and innovative staff," Bloomsbury said.

Shares in Bloomsbury were trading up 0.81 pence at 173.06 pence Thursday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
19 Mar 2019 11:35

Bloomsbury Publishing ends year in line with expectations

(Sharecast News) - Bloomsbury Publishing issued a pre-close trading update for the 12 months ended 28 February on Tuesday, saying it expected results for the year to be in line with the board's expectations.

Read more
24 Jan 2019 15:09

Thursday broker round-up

(Sharecast News) - Reckitt Benckiser: Jefferies downgrades to underperform with a target price of 5,000p.

Read more
7 Jan 2019 09:02

Bloomsbury Publishing Inks Two Digital Distribution Partnerships

LONDON (Alliance News) - Bloomsbury Publishing PLC said Monday it has partnered with Rowman & Littlefield and Manchester University Press to sell their digital titles.Under the the will

Read more
23 Oct 2018 11:00

WINNERS & LOSERS SUMMARY: Travis Perkins Rises After Strong Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 3.8%, Randgold Resources, a

Read more
23 Oct 2018 10:20

Bloomsbury grows underlying profit as adult books fly off shelves

(Sharecast News) - Bloomsbury Publishing grew underlying profits 13% in the first half of its financial year as revenues were boosted by books by Kamila Shamsie, Anthony Bourdain and continued sales of 'Harry Potter' books.

Read more
23 Oct 2018 09:28

Bloomsbury Publishing Hikes Interim Payout On Broad-Based Sales Rise

LONDON (Alliance News) - Harry Potter-publisher Bloomsbury Publishing PLC boosted its interim dividend Tuesday after revenue rose despite reported profit dipping on one-off costs.For the to

Read more
19 Jul 2018 16:16

UK Dividends Calendar - Next 7 Days

Friday 20 July Air Partnerdividend payment dateTelford Homesdividend payment payment 23

Read more
1 Jun 2018 17:38

DIRECTOR DEALINGS: Bloomsbury Publishing Chief Executive Sells Shares

LONDON (Alliance News) - Bloomsbury Publishing PLC, the publisher of Harry Potter book series, said Chief Executive Nigel Newton sold 130,000 shares at a price of 234.23 pence per share on the 1.0

Read more
22 May 2018 11:58

Bloomsbury Publishing Says New Year Performance Will Be Ahead Of Views

LONDON (Alliance News) - Bloomsbury Publishing PLC said Tuesday its performance in the new financial year will be "well ahead" of expectations, as it reported increased profit and for to

Read more
15 May 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 16 May C&C GroupFull Year ResultsBurberry GroupFull Year & Year Year 17

Read more
1 May 2018 09:51

Bloomsbury Publishing Buys Academic Firm IBT Tauris For GBP5.8 Million

LONDON (Alliance News) - Bloomsbury Publishing PLC said Tuesday it acquired academic publishing firm IBT Tauris & Co Ltd for GBP5.8 million in cash.Harry Potter-publisher Bloomsbury pay

Read more
19 Apr 2018 12:57

Bloomsbury Publishing Appoints Conde Nast Executive New Finance Head

LONDON (Alliance News) - Bloomsbury Publishing PLC said Thursday it has appointed Penny Scott-Bayfield as its new finance director from mid July.Scott-Bayfield will replace incumbent Wendy

Read more
27 Mar 2018 13:57

Reuters Health News Summary

Following is a summary of current health news briefs. Severely elevated cholesterol often goes untreated Many patients with dangerously high cholesterol or a genetic predisposition a

Read more
27 Mar 2018 13:57

Reuters Health News Summary

Following is a summary of current health news briefs. Severely elevated cholesterol often goes untreated Many patients with dangerously high cholesterol or a genetic predisposition a

Read more
26 Mar 2018 21:56

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.